235 related articles for article (PubMed ID: 23817421)
1. A diametric role for OX40 in the response of effector/memory CD4+ T cells and regulatory T cells to alloantigen.
Kinnear G; Wood KJ; Fallah-Arani F; Jones ND
J Immunol; 2013 Aug; 191(3):1465-75. PubMed ID: 23817421
[TBL] [Abstract][Full Text] [Related]
2. Anti-OX40 prevents effector T-cell accumulation and CD8+ T-cell mediated skin allograft rejection.
Kinnear G; Wood KJ; Marshall D; Jones ND
Transplantation; 2010 Dec; 90(12):1265-71. PubMed ID: 21037534
[TBL] [Abstract][Full Text] [Related]
3. Critical, but conditional, role of OX40 in memory T cell-mediated rejection.
Vu MD; Clarkson MR; Yagita H; Turka LA; Sayegh MH; Li XC
J Immunol; 2006 Feb; 176(3):1394-401. PubMed ID: 16424166
[TBL] [Abstract][Full Text] [Related]
4. OX40-OX40 ligand interaction through T cell-T cell contact contributes to CD4 T cell longevity.
Soroosh P; Ine S; Sugamura K; Ishii N
J Immunol; 2006 May; 176(10):5975-87. PubMed ID: 16670306
[TBL] [Abstract][Full Text] [Related]
5. Ligation of OX40 (CD134) regulates graft-versus-host disease (GVHD) and graft rejection in allogeneic bone marrow transplant recipients.
Blazar BR; Sharpe AH; Chen AI; Panoskaltsis-Mortari A; Lees C; Akiba H; Yagita H; Killeen N; Taylor PA
Blood; 2003 May; 101(9):3741-8. PubMed ID: 12521997
[TBL] [Abstract][Full Text] [Related]
6. Costimulation through OX40 is crucial for induction of an alloreactive human T-cell response.
Ukyo N; Hori T; Yanagita S; Ishikawa T; Uchiyama T
Immunology; 2003 Jun; 109(2):226-31. PubMed ID: 12757617
[TBL] [Abstract][Full Text] [Related]
7. OX40 is required for regulatory T cell-mediated control of colitis.
Griseri T; Asquith M; Thompson C; Powrie F
J Exp Med; 2010 Apr; 207(4):699-709. PubMed ID: 20368580
[TBL] [Abstract][Full Text] [Related]
8. Memory T Cells Mediate Cardiac Allograft Vasculopathy and are Inactivated by Anti-OX40L Monoclonal Antibody.
Wang H; Zhang Z; Tian W; Liu T; Han H; Garcia B; Li XC; Du C
Cardiovasc Drugs Ther; 2014 Apr; 28(2):115-22. PubMed ID: 24254032
[TBL] [Abstract][Full Text] [Related]
9. Activated T cells express the OX40 ligand: requirements for induction and costimulatory function.
Mendel I; Shevach EM
Immunology; 2006 Feb; 117(2):196-204. PubMed ID: 16423055
[TBL] [Abstract][Full Text] [Related]
10. Interruption of the OX40-OX40 ligand pathway in LDL receptor-deficient mice causes regression of atherosclerosis.
Foks AC; van Puijvelde GH; Bot I; ter Borg MN; Habets KL; Johnson JL; Yagita H; van Berkel TJ; Kuiper J
J Immunol; 2013 Nov; 191(9):4573-80. PubMed ID: 24068673
[TBL] [Abstract][Full Text] [Related]
11. OX40/OX40L costimulation affects induction of Foxp3+ regulatory T cells in part by expanding memory T cells in vivo.
Xiao X; Kroemer A; Gao W; Ishii N; Demirci G; Li XC
J Immunol; 2008 Sep; 181(5):3193-201. PubMed ID: 18713990
[TBL] [Abstract][Full Text] [Related]
12. Constitutive OX40/OX40 ligand interaction induces autoimmune-like diseases.
Murata K; Nose M; Ndhlovu LC; Sato T; Sugamura K; Ishii N
J Immunol; 2002 Oct; 169(8):4628-36. PubMed ID: 12370402
[TBL] [Abstract][Full Text] [Related]
13. OX40 ligand regulates inflammation and mortality in the innate immune response to sepsis.
Karulf M; Kelly A; Weinberg AD; Gold JA
J Immunol; 2010 Oct; 185(8):4856-62. PubMed ID: 20844189
[TBL] [Abstract][Full Text] [Related]
14. Antagonism of airway tolerance by endotoxin/lipopolysaccharide through promoting OX40L and suppressing antigen-specific Foxp3+ T regulatory cells.
Duan W; So T; Croft M
J Immunol; 2008 Dec; 181(12):8650-9. PubMed ID: 19050285
[TBL] [Abstract][Full Text] [Related]
15. Mast cells counteract regulatory T-cell suppression through interleukin-6 and OX40/OX40L axis toward Th17-cell differentiation.
Piconese S; Gri G; Tripodo C; Musio S; Gorzanelli A; Frossi B; Pedotti R; Pucillo CE; Colombo MP
Blood; 2009 Sep; 114(13):2639-48. PubMed ID: 19643985
[TBL] [Abstract][Full Text] [Related]
16. Strategies to induce marked prolongation of secondary skin allograft survival in alloantigen-primed mice.
Minamimura K; Sato K; Yagita H; Tanaka T; Arii S; Maki T
Am J Transplant; 2008 Apr; 8(4):761-72. PubMed ID: 18261171
[TBL] [Abstract][Full Text] [Related]
17. Blockade of the OX40/OX40L pathway and induction of PD-L1 synergistically protects mouse islet allografts from rejection.
Li T; Ma R; Zhu J; Wang F; Huang L; Leng X
Chin Med J (Engl); 2014; 127(14):2686-92. PubMed ID: 25043090
[TBL] [Abstract][Full Text] [Related]
18. 4-1BB and OX40 act independently to facilitate robust CD8 and CD4 recall responses.
Dawicki W; Bertram EM; Sharpe AH; Watts TH
J Immunol; 2004 Nov; 173(10):5944-51. PubMed ID: 15528328
[TBL] [Abstract][Full Text] [Related]
19. OX40 ligand-transduced tumor cell vaccine synergizes with GM-CSF and requires CD40-Apc signaling to boost the host T cell antitumor response.
Gri G; Gallo E; Di Carlo E; Musiani P; Colombo MP
J Immunol; 2003 Jan; 170(1):99-106. PubMed ID: 12496388
[TBL] [Abstract][Full Text] [Related]
20. PKC-ѳ is dispensable for OX40L-induced TCR-independent Treg proliferation but contributes by enabling IL-2 production from effector T-cells.
Alharshawi K; Marinelarena A; Kumar P; El-Sayed O; Bhattacharya P; Sun Z; Epstein AL; Maker AV; Prabhakar BS
Sci Rep; 2017 Jul; 7(1):6594. PubMed ID: 28747670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]